VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1486113
Sex: M
Age:
State: AZ

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Dehydration; Symptoms of the flu; Soreness; Unable to sleep; Aches in joints; Nausea; Fever; Tiredness; This is a spontaneous report from a contactable other healthcare professional. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: er8732) via an unspecified route of administration in the left arm on 30Mar2021 at 13:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: er8732) via an unspecified route of administration in the left arm on an unspecified date in Mar2021 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 the patient experienced dehydration, aches in joints, nausea, fever, soreness, symptoms of the flu, tiredness and unable to sleep. The adverse events did not result in a visit to the doctors or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events dehydration, aches in joints, nausea, fever, soreness, symptoms of the flu, tiredness and unable to sleep were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486114
Sex: F
Age:
State:

Vax Date: 03/30/2021
Onset Date: 03/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Very bad nausea; Dizziness; This is a spontaneous report received from a non-contactable consumer. A 20-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 30Mar2021 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included the patient was allergic to iodine. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On an unknown date in Mar2021, the patient experienced very bad nausea and dizziness. The patient did not receive any treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events nausea and dizziness was resolved with lasting effects on unspecified date in Mar2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486115
Sex: M
Age:
State: AZ

Vax Date: 03/28/2021
Onset Date: 03/29/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Burning to the touch sensation in leftleg. From upper groin to bottom of feet; This is a spontaneous report received from a contactable consumer, the patient. A 47-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8730) via an unspecified route of administration in the left arm on 28Mar2021 at 01:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included graves' disease. Concomitant medications included thiamazole (METHIMAZOLE) for an unknown indication and from an unknown date. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 04:00, the patient experienced burning to touch sensation in left leg, from upper groin to bottom of feet. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event burning sensation in left leg from upper groin to bottom of feet was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METHIMAZOLE

Current Illness:

ID: 1486116
Sex: F
Age:
State: UT

Vax Date: 02/12/2021
Onset Date: 02/15/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Chills; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL9267) via unspecified route of administration in the left arm on 12Feb2021 at 11:00 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included hoshimotos disease, blood pressure high and osteopenia. The patient had a known allergy to penicillin. The patient concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN), telmisartan (MANUFACTURER UNKNOWN) and Metoprolol succinate (TOPROL-XL) received within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3247) via unspecified route of administration in the left arm on 22Jan2021 at 11:00 (at the age of 72-years-old) as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 15Feb2021, the patient experienced chills 2 days after the second vaccination with 2 hours of duration and had it for every two to three days since last 7 weeks approximately and sometimes more than once a day/ night. On 10Mar2021, the patient underwent COVID-19 test (nasal swab) and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of chills. The clinical outcome of the event chills was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: ROSUVASTATIN; TELMISARTAN; TOPROL XL

Current Illness:

ID: 1486117
Sex: M
Age:
State: IL

Vax Date: 03/24/2021
Onset Date: 03/27/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Ear infection; Ear was slightly tender; Scrating caused it to become inflamed; Ear hurts; Ear is now filled with fluids; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732), via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 23-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. Concomitant medications included minoxidil (ROGAINE) and multivitamin (MANUFACTURER UNKNOWN); both taken for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 20:00 the patient experienced ear infection. The patient did not leave the house and had not interacted with anyone. The patient noticed that ear was slightly tender and had agitated by scratching which caused it to become inflamed. The patient reported that ear was filled with fluids and that it hurt. The patient experienced ear infection frequently when patient had cold, and thought the vaccine made his body to react in the same way. On 29Mar2021, the patient was tested for COVID-19 virus test which resulted in negative. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of ear infection, tenderness, inflammation, ear pain and fluid in middle ear which included treatment with amoxicillin (MANUFACTURER UNKNOWN). The clinical outcomes of the events ear infection, tenderness, inflammation, ear pain and fluid in middle ear were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ROGAINE

Current Illness:

ID: 1486118
Sex: F
Age:
State: GA

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: General yucky feeling; Fever; Chills; Nausea; Swollen lymph nodes; Fatigue; Muscle aches; Headache; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 14:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes type 1 and irritable bowel syndrome-diarrhea (IBS-D). The patient was allergic to tuberculosis (TB) skin test and curry. Concomitant medications included insulin lispro (HUMALOG) and loratadine (CLARITIN) since an unknown date for unknown indication. The patient previously received unspecified meningitis vaccine (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced allergy to vaccine. The patient also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in left arm on 08Mar2021 at 13:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 01:00, the patient experienced fever, chills, nausea, swollen lymph nodes, fatigue, muscle aches, headache and general yucky feeling. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fever, chills, nausea, swollen lymph nodes, fatigue, muscle aches, headache and general yucky feeling were resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: HUMALOG; Claritin

Current Illness:

ID: 1486119
Sex: M
Age:
State: MI

Vax Date: 03/29/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Rash in the right arm around the injection site; Burning sensation in the right arm around the injection site; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Mar2021 at 14:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and diabetes. The patient had no known allergies. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), metoprolol tartrate (MANUFACTURER UNKNOWN), metformin((MANUFACTURER UNKNOWN) and atropine (MANUFACTURER UNKNOWN) taken for unknown indication from an unspecified date. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 08Mar2021 at 14:30 ( at the age of 39-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 13:00, the patient experienced rash and burning sensation on his right arm around the injection site (vaccination site rash ; vaccination site burning). The events happened 2 days after the shot (as reported). The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events rash in the right arm around the injection site and burning sensation in the right arm around the injection site was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: METOPROLOL TARTRATE; LISINOPRIL; METFORMIN; ATROPINE

Current Illness:

ID: 1486120
Sex: F
Age:
State: OH

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Muscle pain in arm, neck, upper back on side vaccine was administered; Stomach upset; Mild headache; sore throat; fatigue; metal taste in mouth; Feel a bit like the flu but with no fever; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the arm left on 30Mar2021 at 16:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to multiple herbs, spice and some medication (unspecified). Concomitant medications received within 2 weeks of vaccination included hydroxyzine hydrochloride (VISTARIL). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 30Mar2021 at 19:00, the patient experienced muscle pain in arm, neck, upper back on the side of vaccine administered, stomach upset, mild headache, sore throat, fatigue, metal taste in mouth and felt a bit like flu but with no fever. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of muscle pain in arm, neck, upper back on side vaccine was administered, stomach upset, mild headache, sore throat, fatigue, metal taste in mouth and feel a bit like flu was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Vistaril

Current Illness:

ID: 1486121
Sex: F
Age:
State: CA

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: injection site pain; fatigue; headache; fuzzy headedness; muscle pain; joint pain generally with focus on left knee; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm left on 12Feb2021 at 01:00 (at the age of 70-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the arm left on 05Mar2021 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. The patient medical history included seasonal allergies. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 12Feb2021, the patient experienced injection site pain (vaccination site pain), fatigue, headache, fuzzy headedness, muscle pain and joint pain generally with focus on left knee. The reported adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received chiropractic treatment at 6 weeks from the first dose. The clinical outcomes of the events injection site pain, fatigue, headache, fuzzy headedness, muscle pain, joint pain generally with focus on left knee were resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486122
Sex: U
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: severe fast/rapid/speeding heartbeat; This is a spontaneous report from a contactable consumer. This consumer reported for another patient that: A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date patient experienced severe fast/rapid/speeding heartbeat. Reporter stated that the technician doing the EKG said that she was the fourth person with speeding/rapid heart rate from the Pfizer vaccine. The outcome of the event was reported as unknown. Information about Lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021358507 same reporter/drug/AE, different patient

Other Meds:

Current Illness:

ID: 1486123
Sex: F
Age:
State: MN

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Insomnia; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration in the left arm on 31Mar2021 at 14:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 21:00, the patient experienced insomnia. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the insomnia was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486124
Sex: M
Age:
State: CT

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Headache; Joint aches; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 31Mar2021 at 10:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the arm left on 10Mar2021 at 11:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 01Apr2021 at 06:00 the patient experienced headache and joint aches. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not received any treatment for the adverse events. The clinical outcome of the adverse events headache and joint aches were resolving. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486125
Sex: F
Age:
State: MI

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Next day past noon, continue fatigue with sweating and chills, followed by fever highest of 102.3 that started at 8pm; Second day, fever continues with muscle/body pain.; Second day, fever continues with muscle/body pain.; Next day past noon, continue fatigue with sweating and chills, followed by fever highest of 102.3 that started at 8pm; Next day past noon, continue fatigue with sweating and chills, followed by fever highest of 102.3 that started at 8pm; pain at site of injection; slight headache at top portion of head; extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 29-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534) via unspecified route of administration in the left arm on 31Mar2021 at 10:30 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. The patient medical history included fibromyalgia and rheumatoid arthritis. The patient had received concomitant medications within two weeks included duloxetine hydrochloride (CYMBALTA) 60 miligrams and meloxicam (MOBIC), from unknown dates for unknown indications. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 14:00, the patient initially had pain at site of injection, slight headache at top portion of head, extreme fatigue. On 01Apr2021 (next day past noon), continued fatigue with sweating and chills, followed by fever highest of 102.3 (unspecified unit) that started at 20:00. On 01Apr2021, second day, fever continued with muscle and body pain. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events vaccination site pain, headache, fatigue, sweating, fever, muscle pain and body pain were resolving at the time of this report No follow-up attempts are needed. No further information is expected.

Other Meds: CYMBALTA; MOBIC

Current Illness:

ID: 1486126
Sex: F
Age:
State: IN

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Rash around injection site on left arm.; swollen lymph nodes under left arm; painful lymph nodes under left arm; Headache; Inappropriate schedule of vaccine administered.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 12:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had allergies to sulfa drugs (unspecified) and codeine (MANUFACTURER UNKNOWN). Concomitant medications included fexofenadine hydrochloride (ALLEGRA), mometasone furoate (NASONEX) and vitamin B complex (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 15Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 31Mar2021 at 18:00, 30 hours after vaccination, the patient experienced rash around injection site on left arm, extremely swollen and painful lymph nodes under left arm and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measure was taken as a result of events. The clinical outcome of the events rash around injection site on left arm, extremely swollen and painful lymph nodes under left arm and headache was not recovered and the outcome of inappropriate schedule of vaccine administration was unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ALLEGRA; NASONEX; B complex

Current Illness:

ID: 1486127
Sex: F
Age:
State: TN

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Body aches; Chills; 102.3 fever; Fatigue; Headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on 30Mar2021 at 12:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration on 09Mar2021 at 11:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced body aches, chills, 102.3 fever, fatigue and headache. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events body aches, chills, 102.3 fever, fatigue and headache. The clinical outcomes of the events body aches, chills, 102.3 fever, fatigue and headache were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486128
Sex: M
Age:
State: KS

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Headache; site soreness; site swelling; nausea; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: eR8727) via an unspecified route of administration in the arm right on 30Mar2021 at 14:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced headache, site soreness, site swelling, nausea and tiredness. The patient did not receive any treatment for the events. The clinical outcome of the events headache, vaccination site pain, vaccination site swelling, nausea and fatigue was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486129
Sex: F
Age:
State: MO

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Moderate to severe injection site pain; Injection site stiffness; muscle aches; chills; a general unwell feeling; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734), via an unspecified route of administration in the left arm on 31Mar2021 at 11:15, (at the age of 42-years old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. On 01Apr2021, at 00:00, the patient experienced moderate to severe injection site pain and stiffness, muscle aches, chills, and a general unwell feeling. The patient woke up at 6:30, on 01Apr2021 feeling stiff and sore, but much better. The patient did not receive any treatment for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe injection site pain, chills, a general unwell feeling, stiffness and muscle aches was recovered on 01Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486130
Sex: M
Age:
State: TN

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Same symptoms as covid !! Cold chills; aching, pain; sick feeling; headache; This is a spontaneous report received from a contactable consumer, the patient. A 56-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8727), via an unspecified route of administration in the left arm on 30Mar2021 at 19:00 (at the age of 56-years-old), as a single dose for COVID-19 immunisation. Medical history included prostate cancer, penicillin allergy and COVID-19 (which was diagnosed prior to the vaccination). Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 20:00 (one day after vaccination), the patient experienced the same symptoms as COVID which includes cold chills, pain, sick feeling and headache. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, pain, feeling sick and headache was resolving at the time of the report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1486131
Sex: F
Age:
State: IN

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: chills; fever; fatigue; face hot to touch; blotchy skin.; Eyes watering; burning of face.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unspecified date in Mar2021 at 13:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic and hypothyroidism. The patient had no known allergies. Concomitant medications included metformin (MANUFACTURER UNKNOWN), semaglutide (OZEMPIC) and levothyroxine sodium (SYNTHROID). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. On an unknown date in Mar2021 at 21:30, the patient experienced chills, fever, and fatigue for the first 2 days, hot to touch and blotchy skin on the fourth day. The patient experienced eyes watering from the burning of face. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatments for the events. The clinical outcomes of the events chills, fever, fatigue, face hot to touch, watering eyes, skin blotches and burning of face were recovering. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: METFORMIN; OZEMPIC; SYNTHROID

Current Illness:

ID: 1486132
Sex: F
Age:
State: NY

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: stomach cramps; fever 99.9; severe chills; medium nausea; mild vomiting, clear, no food; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), aneurysm (metal clips) in Dec1973 and COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), vit d nos (MANUFACTURER UNKNOWN) and probiotic received within 2 weeks of vaccination. The patient had known allergies to NSAIDs and caffeine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 05:10, the patient experienced severe chills, medium nausea, mild vomiting which was clear, no food in it and patient had no temperature. On 01Apr2021 at 07:30, the patient experienced mild vomiting of gastric juices, severe chills, stomach cramps and temperature at 99.9. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care (also reported as, the patient took tablets after conferring with doctor). Therapeutic measures were taken as a result of adverse events included treatment with omeprazole, tylenol once every 4 hours and lots of fluids. The clinical outcomes of severe chills, medium nausea, mild vomiting which was clear and no food, stomach cramps, fever and mild vomiting of gastric juices were recovering at the time of the report. No follow up attempts are need; information about lot number can not be obtained.

Other Meds: Fe; Ca; Mg; Vit D

Current Illness:

ID: 1486133
Sex: F
Age:
State: MI

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 31Mar2021 at 08:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included asthmatic, blood pressure high and type 2 diabetes mellitus. The patient's concomitant medications included unspecified medications for asthmatic, high blood pressure and type 2 diabetes mellitus. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN) via an unspecified route of administration in the right arm on 10Mar2021 at 09:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, on the day of vaccination, the patient experienced a very sore injection site area, itchy face-cheek and felt a little inflamed and fatigue. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events very sore injection site area, itchy face-cheek area, fatigue and inflammation was recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486134
Sex: F
Age:
State: MO

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: swollen lymph node on collarbone area; collarbone on the right side started hurting; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in the right arm on 27Mar2021 at 11:00 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included levocetirizine dihydrochloride (XYZAL) and ethinylestradiol, norgestimate (TRI-SPRINTEC) all from an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the right arm on 06Mar2021 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. The patient did not have a history of allergies to medications, food or other products. The patient had not received other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 23:00, the patient experienced collarbone hurting on the right side and after 2 days on 29Mar2021, the patient had a swollen lymph node on collarbone area, it was currently still swollen. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcomes for the events collarbone hurting and swollen lymph nodes on collarbone area was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: XYZAL; TRI-SPRINTEC

Current Illness:

ID: 1486135
Sex: M
Age:
State: WI

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Couldnt sleep; fluctuating body temperature.; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 31Mar2021 at 10:30 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not take any concomitant medication. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 12:00 the patient was not able to sleep and experienced fluctuating body temperature. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the reported adverse events. The clinical outcome of the event difficulty sleeping and fluctuating body temperature was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486136
Sex: F
Age:
State: NJ

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Fatigue; chills; body ache; brain fog; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 31Mar2021 at 08:15 (at the age of 54-years-old) as a single dose for COVID-19 vaccination. Medical history included chronic hives. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 09:00 the patient experienced brain fog, fatigue, chills, body ache. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of the events brain fog, fatigue, chills, body ache was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486137
Sex: F
Age:
State: PA

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: chills; low grade fever; extremely exhausted; slept most of the day; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 24Mar2021 at 09:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included inflamed kidney (right side). Concomitant medications included ethinylestradiol (+) norgestimate (ORTHO TRI-CYCLEN LO), vitamin D NOS (MANUFACTURER UNKNOWN) and sertraline (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 03Mar2021 at 09:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. On 25Mar2021, the patient woke up at 02:00 with chills which then felt like it turned into a low-grade fever. The chills went away in the early morning, but then the patient was extremely exhausted and slept most of the day. The patient reported that she felt better the following day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events chills, low grade fever, extremely exhausted and slept most of the day were recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ORTHO TRI-CYCLEN LO; VITAMIN D NOS; SERTRALINE

Current Illness:

ID: 1486138
Sex: F
Age:
State: CO

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Right eye pain when blinking.; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: FR8734) via an unspecified route of administration in the right arm on 29Mar2021 at 11:45 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and high cholesterol. The patient did not have any allergies to medications, food, or other products. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) and hydrochlorothiazide, lisinopril (LISINOPRIL HCT). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. One day after vaccination, on 30Mar2021, the patient experienced mild but definitely noticeable right eye pain when blinking and that was lasted for about 8 hours. It was felt like a hard contact lenses were in upper part of eye. After a few hours, it occurred to the patient to check the internet to see if that was related to the vaccine, and then she found many similar reports. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event right eye pain when blinking was resolved on 30Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ATORVASTATIN; Lisinopril hct

Current Illness:

ID: 1486139
Sex: F
Age:
State: NJ

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Diarrhea; Achy; Throwing up all day; Fever; Chills on and off; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the arm left on 29Mar2021 at 09:30 (inappropriate schedule of vaccine administered) (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included interstitial cystitis. The patient never had any allergy to medication, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included unspecified multivitamins (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the arm left on 11Mar2021 at 01:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient reported that, she was fine on the first day till 01:00, eleven hours after the vaccination (as reported- discrepancy). On 30Mar2021 at 01:00, she threw up all day, fever of 100 (unspecified units), and had chills on and off. On 31Mar2021, the patient still felt like she wanted to throw up, she still had chills and felt achy. On 01Apr2021 at 02:00, the patient experienced diarrhea and still felt like she wanted to throw up. The adverse events did not result in a doctor or other healthcare professional office/ clinic visit/ emergency room/ department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events felt like throwing up, fever, chills, achy and diarrhea were not resolved at the time of this report. The clinical outcome of the event inappropriate schedule of vaccine was unknown at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486140
Sex: M
Age:
State: MA

Vax Date: 02/17/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Sore throat; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 17Feb2021 at 09:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atorvastatin calcium (LIPITOR), sertraline hydrochloride (ZOLOFT), ascorbic acid/vitamin C (MANUFACTURER UNKNOWN) and multi vitamin (CENTRUM). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 27Jan2021 at 09:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Feb2021, the patient underwent a rapid test (nasal swab) for COVID-19 and tested negative. On 30Mar2021 at 21:00, the patient experienced a sore throat and reported that he would get a COVID-19 test done as a precautionary measure. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event sore throat was resolved on an unspecified date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LIPITOR; ZOLOFT; Vitamin c

Current Illness:

ID: 1486141
Sex: F
Age:
State: MI

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Fever; Aches; Exhaustion; Headache; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration in the left arm on 29Mar2021 at 00:00 (at the age of 63-years-old), as a single dose for Covid-19 immunisation. Medical history included high blood pressure and COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medication included paroxetine (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), propanol (MANUFACTURER UNKNOWN) and losartan hydrochlorothiazide (MANUFACTURER UNKNOWN); all taken for unknown indication from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 08Mar2021 at 00:00 (at the age of 63-years-old), as a single dose for Covid-19 immunisation. The patient was diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 20:00, the patient experienced fever, aches, exhaustion, headache and vomiting for four days. The patient received acetaminophen (MANUFACTURER UNKNOWN) and antacids (MANUFACTURER UNKNOWN) as a treatment drugs for the fever, aches, exhaustion, headache and vomiting. The clinical outcome of fever, aches, exhaustion, headache and vomiting was not resolved at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: PROPANOL; PAROXETINE; METFORMIN; LOSARTAN HYDROCHLOROTHIAZIDE TEVA

Current Illness:

ID: 1486142
Sex: F
Age:
State: PA

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Chills; body aches; muscle pain; Nausea; migraine; fever of 100.7; light headedness; heavy chest discomfort; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via an unspecified route of administration in the right arm on 30Mar2021 at 14:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis. The patient did not have any known allergy. Concomitant medications included sertraline hydrochloride (ZOLOFT), doxycycline (MANUFACTURER UNKNOWN), calcium carbonate (TUMS), vitamin D (MANUFACTURER UNKNOWN), B12 (MANUFACTURER UNKNOWN) and meloxicam (MELOXIC). Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 15:45 (also reported as between 16:00 to 23:00), the patient experienced chills, body aches, muscle pain, nausea, migraine, fever of 100.7, light headedness and heavy chest discomfort. The patient did not receive any treatment for the events. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, body aches, muscle pain, nausea, migraine, fever of 100.7, light headedness and heavy chest discomfort was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT; DOXYCYCLINE; Tums; Vitamin D; MELOXIC

Current Illness:

ID: 1486143
Sex: F
Age:
State: CA

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Flu like symptoms; feeling awful; . Body aches; fatigue; vaccination site pain; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 30Mar2021 at 14:00(at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, graves' disease and depression. The patient had no known allergy. Concomitant medications included losartan (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), thyroid (MANUFACTURER UNKNOWN) and paroxetine hydrochloride (PAXIL) from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 1400 the patient experienced injection site hurt and on 31Mar2021 at 07:00 the patient experienced flu like symptoms, body ache and fatigue (so that the patient couldn't work) and feeling awful to sit up in bed was painful for the patient. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient included treatment with ADVIL for the adverse events and slept the entire day. The clinical outcome of the events of flu like symptoms, body ache, fatigue, injection site hurt and feeling awful was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN; METOPROLOL; THYROID; Paxil

Current Illness:

ID: 1486144
Sex: F
Age:
State: KY

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Vaccination site pain; Headache; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er8734) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient had no allergies to medications, food or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 31Mar2021 at 18:00, the patient experienced vaccination site pain and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures included treatment with tylenol for the reported events. The clinical outcome of the events vaccination site pain and headache were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486145
Sex: F
Age:
State: MN

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: left palm turned yellow; This is a spontaneous report from a contactable other healthcare professional, the patient. A 26-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Jan2021 at 09:15 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Concomitant medications included fish oil (MANUFACTURER UNKNOWN), cranberrysup (MANUFACTURER UNKNOWN), UTHealthSup (MANUFACTURER UNKNOWN), cla130 (MANUFACTURER UNKNOWN) and allergy medications (unspecified) for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Jan2021 at 10:00 the patient experienced left palm turned yellow, like a highlighter was broke in it. After receiving vaccine, 45 minutes later when patient got back to work, noticed that palm had turned yellow. The patient reported that three months later too palm was still yellow. The patient reported it to be brighter some days than other days and that yellow seemed to be spread down fingers slowly. The patient reported that she received second shot in the right arm to see if its similar thing would happen again; but it did not. The patient reported that had no discomfort, pain or itching. No therapeutic measures were taken as a result of the reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event left palm turned yellow was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: FISH OIL

Current Illness:

ID: 1486146
Sex: F
Age:
State: OH

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Right arm pit is sore; Right arm pit swollen.; Possibly the lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 29Mar2021 at 17:00(at the age of 59-year-old), as a single dose for COVID-19 immunisation. Medical history included blood pressure high, iodine allergy and shellfish allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 08Mar2021 at 17:00 (at the age of 59-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 06:00, the patient experienced under right arm, in the armpit was sore and swollen. Possibly the lymph nodes. The patient did not receive any treatment for the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events right arm pit sore, swollen and swollen lymph nodes were not recovered at the time of reporting. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486147
Sex: F
Age:
State: MD

Vax Date: 03/20/2021
Onset Date: 03/22/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Eignt days after, slept as muchas 13-14 hours (normally 7.5 hours).; shingles; tired; No stamina; Thinking is slower; joint stiffness in am; muscle aches; burning sensations in palms and lower legs; ribs ache; This is a spontaneous report received from a contactable healthcare professional, the patient. A 65-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206), via an unspecified route of administration in the left arm on 20Mar2021 at 14:45 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included shingles and lyme disease. The patient was known allergic to codeine (MANUFACTURER UNKNOWN), jellyfish and latex. The patient did not receive any medication within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021, within 48 hours, the patient experienced shingles, increasingly tired over the next 12 days. On 28Mar2021, eight days after the vaccination, the patient slept as much as 13-14 hours (normally 7.5 hours) (hypersomnia). It was reported that the patient had no stamina, cannot work for more than a couple hours and thinking was slower than usual and had some joint stiffness. The adverse events resulted in a doctors or other healthcare visit/professional office/clinic visit. The patient did not receive any treatment for the reported events. The clinical outcome of the events shingles, increasingly tired, the patient slept as much as 13-14 hours normally 7.5 hours , no stamina, thinking was slower, joint stiffness in arm, muscle aches, burning sensations in palms and lower legs and ribs ache was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486148
Sex: F
Age:
State: WV

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: High Blood pressure; cluster headaches; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 25Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient previously took vaccine for shingles in the left arm on 02Feb2021 within four weeks prior to the COVID-19 vaccination. Medical history included thyroid, high cholesterol. The patient was allergic to sulfa drugs. Concomitant medications included levothyroxine sodium (SYNTHROID), rosuvastatin calcium (CRESTOR) and montelukast sodium (SINGULAIR) from an unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021, the patient experienced high blood pressure and cluster headaches for a week. Blood pressure normally on the low end, and it was running 150/100 (unspecified units). It was unknown if the patient received treatment for the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event high blood pressure and cluster headaches were unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: SYNTHROID; CRESTOR; SINGULAIR

Current Illness:

ID: 1486149
Sex: F
Age:
State: OK

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: also had a headache that increasingly got worse until EMS arrived; Patient had pain radiating down from injection site; This is a spontaneous report from a contactable healthcare professional reporting for a patient. A 19-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 31Mar2021 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications. The patient did not have allergy to medications, food, or other products. It was reported as unknown about the pregnancy information. Prior to the vaccination, the patient diagnosed with COVID-19 was unknown. It was reported as unknown that the patient received any other vaccines within four weeks prior to the vaccination. Since the vaccination, it was unknown that the patient had been tested for COVID-19. On 31Mar2021 at 17:15 the patient experienced pain radiating down from injection site, headache worsened till EMS arrived. The event resulted in emergency room/department or urgent care. The treatment taken for the adverse events was unknown. The clinical outcome of the events pain radiating down from injection site and headache were unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486150
Sex: F
Age:
State: CA

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Hives all over body; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8737) via an unspecified route of administration in the left arm on 29Mar2021 at 10:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies to medications and food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er16199) via an unspecified route of administration in the left arm on 08Mar2021 at 17:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had tested for COVID-19. The patient underwent lab test post vaccination, which included nasal swab test on an unknown date in 2021 and the result was unknown. On 30Mar2021 at 16:00, the patient experienced hives all over the body. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient had taken self-dosing of BENADRYL as treatment for event hives all over body. The clinical outcome of the event hives all over body was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486151
Sex: M
Age:
State: OH

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Horrible arm pain ( On a scale of 1-10it was an 11); Redness at injection site; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 31Mar2021 at 08:15 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no allergies to medications, food, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 22:45, the patient experienced horrible arm pain (On a scale of 1-10, it was an 11), redness at injection site and low grade fever (all these reaction had started after 14 hours of injection). The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event painful arm, injection site redness and low grade fever was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486152
Sex: F
Age:
State: MI

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: A large blister formed at the injection site; Resting heart rate has decreased suddenly from about 70 bpm to 66 bpm.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 14:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have a history of allergies to medications, food, or other products. The patient did not receive any other medications within two weeks of COVID-19 vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021, the patient experienced a large blister formed at the injection site hours after the injection and was persisting 4 days afterwards, and her resting heart rate was also decreased suddenly from about 70 bpm to 66 bpm. The patient contacted her doctor (left a message), and was waiting to hear back about what to do. No therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events large blister formed at the injection site and heart rate decreased was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486153
Sex: F
Age:
State: WI

Vax Date: 03/23/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: large raised bump on injection site; injection site itchy; injection site red.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8730), via an unspecified route of administration in the left arm on 23Mar2021 at 09:00 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included venlafaxine (MANUFACTURER UNKNOWN) and valsartan (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 30Mar2021 (also reported as 8 days after vaccination), the patient experienced large raised bump on injection site, itching and redness. The adverse events did not result in a visit to the doctors or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events large raised bump on injection site, itchy and redness were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VENLAFAXINE; VALSARTAN

Current Illness:

ID: 1486154
Sex: F
Age:
State:

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Pain at the site of the shot; chills; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 30Mar2021 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 11:30, the patient had pain at the site of the shot, chills and headache. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events pain at the site of the shot, chills and headache which included treatment with paracetamol (TYLENOL). The clinical outcomes of the events pain at the site of the shot, chills and headache were resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486155
Sex: F
Age:
State: NM

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Tingly all over body.; Muscle aches; Arm soreness; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 31Mar2021 at 14:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included muscular dystrophy. The patient had allergies to mangoes. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and cetirizine (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 12Mar2021 at 14:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had not received any other vaccine within 4 weeks prior to the COVID vaccine. On 31Mar2021 at 14:00, the patient experienced tingly all over the body, muscle aches and arm soreness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measure was taken as a result of adverse events. The clinical outcome of the events was not recovered at the time of this report. No follow-up attempts are needed. Information about lot/batch number cannot be obtained.

Other Meds: IBUPROFEN; CETRIZINE

Current Illness:

ID: 1486156
Sex: F
Age:
State: NC

Vax Date: 03/24/2021
Onset Date: 03/29/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: bright red rash; sore area on right arm; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the right arm on 24Mar2021 at 20:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were reported as "too long to list-can provide a list if contacted directly". The patient had history of known allergies to adhesives. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration on 03Mar2021 at 13:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation and cefprozil (CEFZIL) on an unknown date for an unspecified indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021, the patient firstly had noticed bright red rash and sore area on her right arm near the injection site, but it was very small and it became larger on 01Apr2021, measured approximately 17cm by 6cm in a parallelogram at the time of reporting. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of bright red rash and sore area on right arm were not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486157
Sex: F
Age:
State: OH

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Period is very late; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 26Mar2021 at 11:30 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) taken for unknown indication and unknown start date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021, the patient was supposed to start period the day after the vaccine but the patient did not have. The patient menstrual cycle was usually very regular but period was very late and was not pregnant. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the menstruation delayed. The clinical outcome of the event menstruation delayed was unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: SERTRALINE

Current Illness:

ID: 1486158
Sex: F
Age:
State: CO

Vax Date: 03/23/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: rash and swelling around right eye; swelling around right eye; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: UNKNOWN) via an unspecified route of administration on 23Mar2021 at 16:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021, the patient experienced rash and swelling around right eye. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events rash and swelling around right eye was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486159
Sex: M
Age:
State: MI

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: experiencing moderate pain and discomfort in kidneys and bladder.; experiencing moderate pain and discomfort in kidneys and bladder.; experiencing moderate pain and discomfort in kidneys and bladder; experiencing moderate pain and discomfort in kidneys and bladder; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 13:15 hours (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have relevant medical history. The patient was allergic to opiates. The patient did not receive concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 19:30 hours the patient experienced experienced moderate pain and discomfort in kidneys and bladder within 6 hours of vaccination. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event moderate pain and discomfort in kidneys and bladder was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486160
Sex: F
Age:
State: AL

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: extremely tired; sore; sleepy; This is a spontaneous report from a contactable healthcare professional, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732), via an unspecified route of administration on the left arm on 26Mar2021 at 17:30(at the age of 43-year-old), as a single dose for COVID-19 immunisation. Medical history included hypertension and endometriosis. Concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 07:30, the patient experienced extremely tired, sore and sleepy since receiving injection. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extremely tired, sore and sleepy was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486161
Sex: M
Age:
State: NJ

Vax Date: 03/28/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Severe weakness; Chills; Fever (~100f); Joint pain; Headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 28Mar2021 at 18:00(at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included amblyopia, blood pressure high and strabismus. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 03:30, the patient experienced chills, fever (~100f), joint pain, headache, severe weakness. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment with over-the-counter ibuprofen. The clinical outcomes of the event chills, fever (~100f), joint pain, headache, sever weakness were recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE

Current Illness:

ID: 1486162
Sex: F
Age:
State: CA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Body temperature; chills; body aches; This is a spontaneous report received from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er2013) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 12:00 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. The patient's medical history was reported as COVID-19 prior to vaccination. The patient did not have a history of allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in an unspecified anatomical site on an unspecified date (at the age of 52-years-old), as a single dose for COVID-19 immunisation. The patient had not received other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not received any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021 at 22:00, the patient experienced 99.9 temperature with chills and body aches, similar to when she had Covid-19 in Dec2020. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. On an unspecified date, the patient underwent body temperature recording and the result was temperature 99.9(unspecified units). The clinical outcomes for the events 99.9 temperature with chills and body aches was recovered in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm